CARL ALLEN to Langerhans Cells
This is a "connection" page, showing publications CARL ALLEN has written about Langerhans Cells.
Connection Strength
2.414
-
The coming of age of Langerhans cell histiocytosis. Nat Immunol. 2020 01; 21(1):1-7.
Score: 0.684
-
Langerhans Cell Histiocytosis: Emerging Insights and Clinical Implications. Oncology (Williston Park). 2016 Feb; 30(2):122-32, 139.
Score: 0.522
-
Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? Br J Haematol. 2015 Apr; 169(1):3-13.
Score: 0.481
-
Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol. 2010 Apr 15; 184(8):4557-67.
Score: 0.347
-
BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology. Nat Med. 2021 05; 27(5):851-861.
Score: 0.188
-
RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions. J Exp Med. 2018 01 02; 215(1):319-336.
Score: 0.149
-
BRAFV 600E or mutant MAP2K1 human CD34+ cells establish Langerhans cell-like histiocytosis in immune-deficient mice. Blood Adv. 2020 10 13; 4(19):4912-4917.
Score: 0.045